Immunocytochemical determination of the estrogen-regulated proteins Mr 24, 000, Mr 52, 000 and DF3 breast cancer associated antigen: Clinical value in advanced breast cancer and correlation with estrogen receptor (Q68156853)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 January 1992

Language	Label	Description	Also known as
English	Immunocytochemical determination of the estrogen-regulated proteins Mr 24, 000, Mr 52, 000 and DF3 breast cancer associated antigen: Clinical value in advanced breast cancer and correlation with estrogen receptor	scientific article published on 01 January 1992

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1606073%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

Immunocytochemical determination of the estrogen-regulated proteins Mr 24,000, Mr 52,000 and DF3 breast cancer associated antigen: clinical value in advanced breast cancer and correlation with estrogen receptor (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1606073%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

Immunocytochemical determination of the estrogen-regulated proteins Mr 24, 000, Mr 52, 000 and DF3 breast cancer associated antigen: Clinical value in advanced breast cancer and correlation with estrogen receptor (English)

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058078

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058078

14 October 2022

1 reference

based on heuristic

inferred from title

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058078

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058078

14 October 2022

author name string

L. Damstrup

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1606073

14 October 2022

J. Andersen

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1606073

14 October 2022

D. W. Kufe

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1606073

14 October 2022

D. F. Hayes

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1606073

14 October 2022

H. S. Poulsen

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1606073

14 October 2022

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1606073

14 October 2022

publication date

1 January 1992

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1606073%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

full work available at URL

http://annonc.oxfordjournals.org/cgi/content/abstract/3/1/71

online access status

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1606073

14 October 2022

https://api.elsevier.com/content/article/PII:S092375341965132X?httpAccept=text/xml

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058078

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058078

14 October 2022

https://api.elsevier.com/content/article/PII:S092375341965132X?httpAccept=text/plain

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058078

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058078

14 October 2022

http://academic.oup.com/annonc/article-pdf/3/1/71/388625/3-1-71.pdf

Portable Document Format

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058078

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058078

14 October 2022

Annals of Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1606073%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1606073%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1606073%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

71-77

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1606073%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

Estrophilin assays in breast cancer: quantitative features and application to the mastectomy specimen

1

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058078

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058078

14 October 2022

The value of estrogen and progesterone receptors in the treatment of breast cancer

2

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058078

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058078

14 October 2022

Estrogen induced synthesis of specific proteins in human breast cancer cells

4

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058078

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058078

14 October 2022

Estradiol stimulates synthesis of a major intracellular protein in a human breast cancer cell line (MCF-7)

5

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058078

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058078

14 October 2022

Quantitative enzyme-linked immunosorbent assay for the estrogen-regulated Mr 24,000 protein in human breast tumors: correlation with estrogen and progesterone receptors

6

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058078

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058078

14 October 2022

Characterization of monoclonal antibodies to the estrogen-regulated Mr 52,000 glycoprotein and their use in MCF7 cells

9

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058078

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058078

14 October 2022

Characterization and properties of two monoclonal antibodies specific for the Mr 52,000 precursor of cathepsin D in human breast cancer cells

10

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058078

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058078

14 October 2022

Differential Reactivity of a Novel Monoclonal Antibody (DF3) with Human Malignant versus Benign Breast Tumors

11

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058078

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058078

14 October 2022

Sodium butyrate induction of milk-related antigens in human MCF-7 breast carcinoma cells

12

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058078

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058078

14 October 2022

Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer

13

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058078

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058078

14 October 2022

Asymptotically Efficient Rank Invariant Test Procedures

16

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058078

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058078

14 October 2022

A generalized Wilcoxon test for comparing arbitrarily singly-censored samples

17

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058078

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058078

14 October 2022

Purification of an estrogen-regulated breast cancer protein by monoclonal antibody affinity chromatography

18

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058078

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058078

14 October 2022

Detection of a Mr 24,000 estrogen-regulated protein in human breast cancer by monoclonal antibodies

19

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058078

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058078

14 October 2022

Semiquantitative oestrogen receptor assay in formalin-fixed paraffin sections of human breast cancer tissue using monoclonal antibodies

20

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058078

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058078

14 October 2022

Immunohistochemical demonstration of estrogen receptors (ER) in formalin-fixed, paraffin-embedded human breast cancer tissue by use of a monoclonal antibody to ER.

21

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058078

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058078

14 October 2022

Immunocytochemical determination of the estrogen-regulated protein Mr 24,000 in primary breast cancer and response to endocrine therapy

22

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058078

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058078

14 October 2022

Immunodetection of estrogen receptor and 52,000-dalton protein in fine needle aspirates of breast cancer tumors

23

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058078

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058078

14 October 2022

Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer

25

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058078

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058078

14 October 2022

Monoclonal antibody DF3 correlates with tumor differentiation and hormone receptor status in breast cancer patients

26

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058078

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058078

14 October 2022

Clinical significance of the quantitative assessment of estrogen receptors in advanced breast cancer.

27

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058078

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058078

14 October 2022

Prediction of prognosis in primary breast cancer by detection of a high molecular weight mucin-like antigen using monoclonal antibodies DF3, F36/22, and CU18: a Cancer and Leukemia Group B study

29

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058078

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058078

14 October 2022

Identifiers

10.1093/OXFORDJOURNALS.ANNONC.A058078

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1606073%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1606073%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q68156853&oldid=1750482625"